• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部腺样囊性癌总生存预测列线图的建立与验证。

Development and validation of a nomogram for predicting overall survival of head and neck adenoid cystic carcinoma.

机构信息

Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, Fujian, China.

Medical Record Room, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China.

出版信息

Sci Rep. 2024 Nov 2;14(1):26406. doi: 10.1038/s41598-024-77322-9.

DOI:10.1038/s41598-024-77322-9
PMID:39488563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11531573/
Abstract

This study aimed to develop and validate a nomogram using clinical variables to guide personalized treatment strategies for adenoid cystic carcinoma of the head and neck (ACCHN). Data from 1069 patients with ACCHN diagnosed between 2004 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) database were used to construct the nomogram. External validation was performed using an independent cohort of 70 patients from Fujian Cancer Hospital. Multivariate Cox regression analysis was conducted using IBM SPSS version 26.0 and R Software version 4.2.3. The concordance index (C-index) and receiver operating characteristic (ROC) curves were used to assess the predictive accuracy of the nomogram. Age, tumor site, surgery, N stage, M stage, and TNM stage were identified as independent prognostic factors through univariate and multivariate Cox analyses. The nomogram demonstrated superior predictive performance compared to the TNM staging system, effectively stratifying patients into high-risk and low-risk groups. This nomogram offers a valuable tool for predicting overall survival in patients with ACCHN and tailoring individualized treatment approaches.

摘要

本研究旨在开发和验证一种列线图,使用临床变量指导头颈部腺样囊性癌(ACCHN)的个体化治疗策略。使用来自监测、流行病学和最终结果(SEER)数据库的 2004 年至 2015 年间诊断为 ACCHN 的 1069 名患者的数据构建列线图。使用来自福建肿瘤医院的 70 名患者的独立队列进行外部验证。使用 IBM SPSS 版本 26.0 和 R 软件版本 4.2.3 进行多变量 Cox 回归分析。使用一致性指数(C 指数)和接收者操作特征(ROC)曲线评估列线图的预测准确性。通过单变量和多变量 Cox 分析确定年龄、肿瘤部位、手术、N 分期、M 分期和 TNM 分期是独立的预后因素。与 TNM 分期系统相比,该列线图具有更好的预测性能,能够有效地将患者分为高危和低危组。该列线图为预测 ACCHN 患者的总生存率和制定个体化治疗方法提供了有价值的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/7805323528ce/41598_2024_77322_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/f2b51f179a2e/41598_2024_77322_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/3b7b578d8ae1/41598_2024_77322_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/d8b5256478ae/41598_2024_77322_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/ed2de5116ec4/41598_2024_77322_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/7805323528ce/41598_2024_77322_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/f2b51f179a2e/41598_2024_77322_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/3b7b578d8ae1/41598_2024_77322_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/d8b5256478ae/41598_2024_77322_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/ed2de5116ec4/41598_2024_77322_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eac1/11531573/7805323528ce/41598_2024_77322_Fig5_HTML.jpg

相似文献

1
Development and validation of a nomogram for predicting overall survival of head and neck adenoid cystic carcinoma.头颈部腺样囊性癌总生存预测列线图的建立与验证。
Sci Rep. 2024 Nov 2;14(1):26406. doi: 10.1038/s41598-024-77322-9.
2
Prognostic Model and Nomogram for Early-Onset Adenoid Cystic Carcinoma of Head and Neck: A Retrospective SEER-Based Analysis.基于 SEER 回顾性分析的头颈部早发性腺样囊性癌预后模型和列线图。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231163026. doi: 10.1177/15330338231163026.
3
Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.基于监测、流行病学和最终结果(SEER)数据库预测直肠鳞状细胞癌患者总生存期的列线图:一项基于人群的加强观察性研究报告(STROBE)队列研究
Medicine (Baltimore). 2019 Nov;98(46):e17916. doi: 10.1097/MD.0000000000017916.
4
Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.基于 SEER 数据库的列线图模型构建与验证:用于预测小肠腺癌患者癌症特异性生存的研究。
World J Surg Oncol. 2024 Jun 7;22(1):151. doi: 10.1186/s12957-024-03438-x.
5
Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.比较头颈部黑色素瘤与身体黑色素瘤患者的特征并预测其生存情况:一项基于人群的研究。
BMC Cancer. 2021 Apr 16;21(1):420. doi: 10.1186/s12885-021-08105-y.
6
Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.膀胱癌生存列线图:利用监测、流行病学和最终结果(SEER)数据库及癌症基因组图谱(TCGA)数据库开发并验证一种预测工具
Medicine (Baltimore). 2019 Nov;98(44):e17725. doi: 10.1097/MD.0000000000017725.
7
A prognostic nomogram for distal bile duct cancer from Surveillance, Epidemiology, and End Results (SEER) database based on the STROBE compliant.基于监测、流行病学和最终结果(SEER)数据库且符合STROBE标准的远端胆管癌预后列线图。
Medicine (Baltimore). 2019 Nov;98(46):e17903. doi: 10.1097/MD.0000000000017903.
8
Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.预测腺样囊性癌患者生存和复发的列线图。一项国际合作研究。
Eur J Cancer. 2015 Dec;51(18):2768-76. doi: 10.1016/j.ejca.2015.09.004. Epub 2015 Nov 19.
9
Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.预测头颈部腺样囊性癌患者特定病因死亡率的模型:一项竞争风险分析
Ann Surg Oncol. 2017 Aug;24(8):2129-2136. doi: 10.1245/s10434-017-5861-z. Epub 2017 Apr 19.
10
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.

本文引用的文献

1
Recent Advances, Systemic Therapy, and Molecular Targets in Adenoid Cystic Carcinoma of the Head and Neck.头颈部腺样囊性癌的最新进展、全身治疗及分子靶点
J Clin Med. 2023 Feb 12;12(4):1463. doi: 10.3390/jcm12041463.
2
Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck.术后放疗在头颈部腺样囊性癌切除术后的作用。
Radiat Oncol. 2022 Dec 1;17(1):197. doi: 10.1186/s13014-022-02165-5.
3
Current opinions on diagnosis and treatment of adenoid cystic carcinoma.当前对腺样囊性癌的诊断和治疗的看法。
Oral Oncol. 2022 Jul;130:105945. doi: 10.1016/j.oraloncology.2022.105945. Epub 2022 Jun 2.
4
Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort.基于 SEER 数据库和外部验证队列的年轻乳腺癌患者生存列线图
Ann Surg Oncol. 2022 Sep;29(9):5772-5781. doi: 10.1245/s10434-022-11911-8. Epub 2022 Jun 3.
5
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.影响复发性和/或转移性涎腺腺样囊性癌患者生存的基线预后因素。
Oral Oncol. 2022 Mar;126:105764. doi: 10.1016/j.oraloncology.2022.105764. Epub 2022 Feb 11.
6
Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis.腺样囊性癌。一种生长缓慢但具有侵袭性的肿瘤。B部分:治疗与预后。
Acta Otorhinolaryngol Ital. 2021 Aug;41(4):296-307. doi: 10.14639/0392-100X-N1729.
7
Prognostic nomogram for adenoid cystic carcinoma in different anatomic sites.不同解剖部位腺样囊性癌的预后列线图
Head Neck. 2021 Jan;43(1):48-59. doi: 10.1002/hed.26443. Epub 2020 Aug 30.
8
Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer.头颈部癌症中的神经周围侵犯和肿瘤沿神经扩散。
Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1109-1124. doi: 10.1016/j.ijrobp.2018.12.009. Epub 2018 Dec 15.
9
Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.头颈部腺样囊性癌的临床结局及预后因素
Anticancer Res. 2017 Jun;37(6):3045-3052. doi: 10.21873/anticanres.11659.
10
Adenoid cystic carcinoma of head and neck: clinical predictors of outcome from a Canadian centre.头颈部腺样囊性癌:来自加拿大一个中心的预后临床预测因素
Curr Oncol. 2016 Feb;23(1):26-33. doi: 10.3747/co.23.2898. Epub 2016 Feb 18.